AI in obs and gynec- pg answer
Reading File
Finding Sources
Searching the Web
AI artificial intelligence obstetrics gynecology PG exam MCQ high yield points 2025
Finding Sources
Reading Web Page
https://pmc.ncbi.nlm.nih.gov/articles/PMC12303583
Searching PubMed
"artificial intelligence" AND "obstetrics" AND "gynecology"
Here is a high-yield, structured answer on AI in Obstetrics & Gynecology for PG (NEET PG / USMLE / FMGE) preparation:
AI in Obstetrics & Gynecology - PG High-Yield Notes
1. Core AI Technologies Used
| Technology | Full Form | Application in OBG |
|---|---|---|
| ML | Machine Learning | Risk prediction models, screening |
| DL / CNN | Deep Learning / Convolutional Neural Networks | Image analysis (USG, colposcopy, pathology) |
| NLP | Natural Language Processing | Clinical notes, EHR mining |
| RNN / LSTM | Recurrent Neural Networks | CTG/fetal heart rate analysis |
| GAN | Generative Adversarial Network | Synthetic data generation, image augmentation |
2. AI in Obstetrics
Prenatal Screening & Imaging
- Nuchal translucency (NT) measurement - AI automates NT measurement on USG, reducing inter-observer variability
- Anomaly scan / fetal biometry - CNNs auto-identify standard fetal planes (e.g., biparietal diameter, abdominal circumference, femur length) with accuracy comparable to expert sonographers
- Placenta previa / accreta - ML models predict placenta accreta spectrum (PAS) using MRI/USG features
- Fetal growth restriction (FGR) - AI risk stratification using Doppler indices + biometry
- Down syndrome / chromosomal anomaly risk - AI-enhanced combined first trimester screening (NT + PAPP-A + beta-hCG)
Intrapartum Monitoring
- Cardiotocography (CTG) / Electronic Fetal Monitoring (EFM) - Most tested PG topic
- AI/deep learning interprets CTG strips to classify: Normal / Suspicious / Pathological
- Reduces inter-observer disagreement (CTG interpretation has ~25% inter-observer variability)
- INFANT trial (UK) - first large RCT of AI-assisted CTG (computerized CTG); did not show significant reduction in adverse outcomes but improved documentation
- Dawes-Redman system - computerized CTG analysis (most widely used); provides automated interpretation
- Key parameters analyzed: baseline FHR, variability, accelerations, decelerations, STV (short-term variability)
Preterm Birth Prediction
- AI models combining cervical length + fibronectin + biomarkers improve prediction of preterm birth
- ML outperforms traditional scoring systems in risk stratification
Preeclampsia Prediction
- AI + sFlt-1/PlGF ratio + MAP + uterine artery PI - used in first trimester screening
- Deep learning models on retinal photographs can predict preeclampsia (retinal vessels reflect systemic vascular changes)
3. AI in Gynecology
Cervical Cancer Screening
- AI-assisted colposcopy - CNNs grade acetowhite areas and mosaic/punctation patterns
- AI-aided Pap smear reading (liquid-based cytology) - automated detection of ASCUS, LSIL, HSIL, carcinoma cells
- HPV triage - ML models risk-stratify HPV-positive women
- VIA (Visual Inspection with Acetic Acid) - AI image analysis improves accuracy in low-resource settings - important for India/developing countries
Endometrial / Uterine Pathology
- AI-assisted hysteroscopy to classify endometrial polyps vs. hyperplasia vs. carcinoma
- MRI-based ML staging of endometrial carcinoma (depth of myometrial invasion)
Ovarian Cancer
- AI analysis of transvaginal USG features (O-RADS scoring system uses standardized lexicon, with AI integration in development)
- Proteomics/genomics ML models for early detection
Infertility & ART (Assisted Reproductive Technology)
- Embryo selection - AI (EmbryoScope time-lapse + ML algorithms) predicts blastocyst viability; iDAScore, KIDScore are commercially available AI embryo scoring tools
- Sperm morphology - automated AI-based sperm analysis (CASA - Computer-Assisted Sperm Analysis)
- Endometrial receptivity - ERA test (Endometrial Receptivity Analysis) uses transcriptomics + ML to time embryo transfer
- Ovarian stimulation protocols - AI optimizes gonadotropin dosing
Gynecologic Oncology
- Robotic surgery (da Vinci system) - AI-assisted robotic surgery for myomectomy, hysterectomy, staging of cancers
- Surgical video analysis - ML tools analyze robotic/laparoscopic videos to assess surgeon skill, detect complications
- Radiomics - extracting quantitative features from CT/MRI/PET images using ML for treatment planning
4. Key FDA-Approved / Clinically Validated AI Tools (PG MCQ Favorites)
| Tool | Application |
|---|---|
| Dawes-Redman system | Computerized CTG analysis (antenatal) |
| INFANT system | Intrapartum CTG decision support |
| EmbryoScope + iDAScore | AI embryo selection in IVF |
| CERVIX AI (Hologic) | Automated Pap smear analysis |
| ThinPrep Imaging System | AI-assisted cervical cytology |
| Butterfly iQ (AI-assisted USG) | Point-of-care obstetric ultrasound |
5. Limitations of AI in OBG (Frequently Asked in Theory/Viva)
- Black box problem - lack of explainability/interpretability (XAI = Explainable AI being developed)
- Algorithmic bias - models trained on non-diverse datasets may underperform in certain ethnic groups
- Data quality issues - garbage in, garbage out
- Legal/ethical concerns - liability in case of AI error
- Not a replacement - AI is decision-support, not autonomous clinical decision-making
- Overfitting in small datasets
- GDPR/privacy concerns with patient data
6. High-Yield PG MCQ Points
Q: Which system is used for computerized CTG analysis antenatally? A: Dawes-Redman system
Q: AI embryo scoring tool used in IVF? A: iDAScore / KIDScore (EmbryoScope)
Q: INFANT trial tested which AI application? A: AI-assisted intrapartum CTG interpretation
Q: Which AI technique is used for USG image analysis? A: Convolutional Neural Network (CNN)
Q: ERA test uses which technology? A: Transcriptomics + Machine Learning (to assess endometrial receptivity)
Q: VIA image analysis by AI is most useful in? A: Cervical cancer screening in low-resource settings
Q: CASA stands for? A: Computer-Assisted Sperm Analysis
7. Quick Summary Table
| Area | AI Application | Key Point |
|---|---|---|
| Antenatal USG | NT measurement, biometry | CNN; reduces observer variability |
| CTG | Automated interpretation | Dawes-Redman; INFANT trial |
| Preeclampsia | sFlt-1/PlGF + MAP + AI | First trimester screening |
| Cervical cancer | Colposcopy, Pap smear, VIA | ThinPrep Imaging System |
| IVF embryo selection | Time-lapse + ML | iDAScore, KIDScore |
| Sperm analysis | CASA | Automated morphology |
| Endometrial receptivity | ERA test | Transcriptomics + ML |
| Gynecologic surgery | Robotic (da Vinci) | AI-assisted surgical guidance |
Bottom line for PG exams: Focus on CTG/AI (Dawes-Redman, INFANT trial), AI embryo selection (iDAScore), ERA test, CNN for imaging, and limitations of AI (bias, black box). These are the most commonly tested concepts across NEET PG, FMGE, and DNB theory papers.
Disadvantages of AI in obs and gynec in simple language
Here are the disadvantages of AI in Obstetrics & Gynecology explained in simple language:
Disadvantages of AI in OBG - Simple Language
1. 🔲 Black Box Problem
Simple: Nobody knows exactly how the AI came to a conclusion.
- The AI gives an answer, but cannot explain why it gave that answer
- A doctor cannot justify a clinical decision to a patient or court by saying "the computer said so"
- Example: AI says a CTG is abnormal - but cannot tell which feature made it abnormal
2. ⚖️ Bias Problem (Unfair to Some Patients)
Simple: AI works well for the people it was trained on, but poorly for others.
- Most AI models are trained on data from Western countries (White/European populations)
- May give wrong risk predictions for Indian, African, or Asian women
- Example: Preeclampsia prediction AI trained on UK data may underperform in Indian patients
- This is a huge concern for countries like India
3. 🗑️ Garbage In, Garbage Out
Simple: If you feed bad data into AI, you get bad results out.
- AI is only as good as the data it is trained on
- Poor quality ultrasound images, incomplete patient records, or wrong labels = unreliable AI
- In rural/low-resource settings, data quality is often poor
4. ❌ Cannot Replace Clinical Judgment
Simple: AI misses things that a doctor picks up from talking to and examining the patient.
- AI works on numbers and images - it cannot feel a uterus, hear a history, or see a patient's face
- It misses the "human context" - patient anxiety, social history, domestic situation
- Example: A CTG may look normal on AI, but the mother says "baby is not moving" - clinical judgment overrides
5. 💰 Cost and Infrastructure
Simple: AI tools are expensive and need good equipment - not available everywhere.
- High cost of AI software, hardware, and maintenance
- Requires good internet, computers, and electricity - not always available in rural India
- Setting up AI in low-resource settings is very difficult
6. ⚖️ Legal and Ethical Issues
Simple: If AI makes a mistake and the baby or mother suffers, who is responsible?
- Is it the doctor's fault? The hospital's? The AI company's?
- No clear legal framework exists yet for AI errors in medicine
- Doctors may over-rely on AI ("automation bias") and miss errors
7. 🔒 Privacy and Data Security
Simple: Patient data used to train AI can be stolen or misused.
- Ultrasound images, lab reports, and genetic data are sensitive
- Risk of data breaches
- Ethical concerns about who owns the patient's data
8. 📉 Overfitting
Simple: AI learns one dataset "too well" and then fails with new patients.
- An AI trained on 1000 patients from one hospital may not work at another hospital
- Poor generalizability across different populations and settings
9. 👩⚕️ Doctor Over-Reliance (Automation Bias)
Simple: Doctors may blindly trust AI and stop thinking for themselves.
- If AI says "normal", the doctor may not look more carefully
- This can lead to missed diagnoses
- Especially dangerous in situations like missed ectopic pregnancy or fetal distress
10. 🔄 Lack of Real-Time Adaptability
Simple: AI does not learn from new patients on its own - it needs regular retraining.
- Medical guidelines change (e.g., new WHO guidelines on preeclampsia)
- Old AI models may give outdated recommendations
- Retraining requires time, money, and new data
Quick Summary Table
| Disadvantage | Simple One-liner |
|---|---|
| Black box | Cannot explain its reasoning |
| Bias | Works poorly for non-Western populations |
| Data quality | Bad input = bad output |
| Misses clinical context | Cannot examine the patient |
| Cost | Expensive, needs good infrastructure |
| Legal issues | Unclear responsibility for errors |
| Privacy | Patient data can be stolen |
| Overfitting | Fails outside its training data |
| Automation bias | Doctors stop thinking independently |
| Not self-updating | Needs regular retraining |
PG exam tip: The most commonly asked disadvantages are black box problem, algorithmic bias, automation bias, legal/ethical issues, and cost. Always remember - AI is a tool to assist, not to replace the clinician.
Last 5 year dnb recent advance paper 4 ques of obgy
Searching the Web
DNB recent advances paper 4 obstetrics gynecology questions 2020 2021 2022 2023 2024
Searching the Web
DNB theory paper obstetrics gynecology recent advances 2022 2023 2024 question paper
Reading Web Page
https://natboard.edu.in/natboard-data/QuestionPaper/MAY24/DN…
Searching the Web
DNB OBG paper 4 recent advances questions 2021 2022 natboard site:natboard.edu.in
Reading Web Page
https://natboard.edu.in/natboard-data/QuestionPaper/JUN22/DN…
Searching the Web
DNB OBG paper 4 questions 2020 2021 recent advances fetal medicine ART robotic surgery
I now have actual DNB Paper 4 questions from the official NBE website for 2021, 2022 (June & Dec), 2023, and 2024. Here is a comprehensive compilation:
DNB OBG Paper 4 - Last 5 Years (2020-2024) - Official Questions
Paper 4 syllabus: Recent Advances + Investigational Technology + ART + Fetal Medicine + Research Methodology + Health Programs + Medical Ethics
📋 MAY 2024 (Official NBE)
| Q No. | Question |
|---|---|
| Q1 | a) Etiologies of non-immune fetal hydrops b) Antenatal evaluation + neonatal workup |
| Q2 | a) Biomedical waste management b) Standard precautions |
| Q3 | a) Components of SUMAN programme + role of obstetricians b) Management of pregnancy in elderly obese woman |
| Q4 | a) WHO Medical Eligibility Criteria (MEC) + MEC wheel b) Antara and Chhaya contraceptives - indications, advantages, disadvantages |
| Q5 | a) ART (Regulation) Act 2021 - components + recent changes b) Surrogacy (Regulation) Act 2021 - pros and cons |
| Q6 | a) Caesarean section audit + role of obstetrician b) Life-threatening conditions in pregnancy due to previous LSCS |
| Q7 | a) Role of MRI in fetal evaluation b) Management of fetal arrhythmias |
| Q8 | a) Preimplantation Genetic Testing (PGT) - types and indications b) Role of ERA (Endometrial Receptivity Array) in IVF |
| Q9 | a) Liquid-based cytology vs conventional Pap smear b) HPV testing - primary screening vs co-testing |
| Q10 | a) Maternal near miss - definition and etiologies b) Audit and surveillance of maternal near miss |
📋 OCT 2023 (Official NBE)
| Q No. | Question |
|---|---|
| Q1 | a) Changes in coagulation factors in pregnancy b) Management of DIC in pregnancy |
| Q2 | a) Components of ERAS (Enhanced Recovery After Surgery) b) Implementation of ERAS in gynaecology practice |
| Q3 | a) Role of colour Doppler in modern day obstetrics b) Intrauterine fetal blood transfusion |
| Q4 | a) Define and classify Ovarian Hyperstimulation Syndrome (OHSS) b) Management of severe OHSS + newer agents |
| Q5 | a) Role of hysteroscopy in modern day ART practice b) Pros and cons of distension media in hysteroscopy |
| Q6 | a) Advantages of recent changes in MTP Act b) Robotic surgery in Gynaecology |
| Q7 | a) Intracytoplasmic Sperm Injection (ICSI) b) Informed consent |
| Q8 | a) PGD (Preimplantation Genetic Diagnosis) - indications + techniques b) Embryo banking |
| Q9 | a) Sentinel lymph node biopsy in gynaecological cancers b) Indocyanine green (ICG) in gynaecological surgery |
| Q10 | a) Telehealth/Telemedicine in obstetrics b) Digital health tools in maternal care |
📋 JUN 2022 (Official NBE)
| Q No. | Question |
|---|---|
| Q1 | a) Etiologies of atypical genital appearance at birth b) Evaluation of neonate with atypical genital appearance (DSD) |
| Q2 | a) Histological classification of VaIN (Vaginal Intraepithelial Neoplasia) b) Management options for VaIN |
| Q3 | a) Role of gynaecologist in RKSK (Rastriya Kishore Swasthya Karyakaram) b) Management of pregnancy in adolescent girl |
| Q4 | a) Components of Family Planning Indemnity Scheme (FPIS) b) Indications, advantages and disadvantages of PPIUCD |
| Q5 | a) Role of epidural analgesia in labour b) Pros and cons of water birth c) Morphine in labour - advantages and disadvantages |
| Q6 | a) Uterus transplant - indications and future perspectives b) Umbilical cord banking - uses and recommendations |
| Q7 | a) Cell-free fetal DNA (cfDNA) / NIPT b) Invasive prenatal diagnosis - amniocentesis vs CVS |
| Q8 | a) Single embryo transfer (SET) - policy and evidence b) Vitrification vs slow freezing of embryos |
| Q9 | a) Robotic surgery - advantages, disadvantages, current status b) Role of simulation in surgical training |
| Q10 | a) Maternal near miss - definition + etiologies b) Workup and audit |
📋 DEC 2022 (Official NBE)
| Q No. | Question |
|---|---|
| Q1 | Cryopreservation of embryo and oocyte - length of preservation and factors influencing pregnancy outcome |
| Q2 | a) Criteria for diagnosis of POI (Premature Ovarian Insufficiency) b) Evaluation and management of POI |
| Q3 | a) Umbilical coiling index and significance b) Types of cord insertion c) Diagnosis and management of vasa previa |
| Q4 | a) Components of publication ethics b) Types of plagiarism c) Methods to avoid plagiarism |
| Q5 | a) Baby Friendly Hospital Initiative (BFHI) b) Kangaroo Mother Care (KMC) |
| Q6 | a) Laparoscopy in pregnancy - indications, timing, safety b) Trocar placement in pregnancy |
| Q7 | a) Endometriosis fertility index (EFI) b) Medical and surgical management of endometriosis-associated infertility |
| Q8 | a) GnRH antagonist protocol in IVF b) Advantages over agonist protocol |
| Q9 | a) BRCA 1 and 2 mutations - significance in gynaecological practice b) Risk-reducing surgery - criteria and timing |
| Q10 | a) Maternal mortality ratio - India vs global b) Strategies to reduce maternal mortality - Sustainable Development Goals |
📋 AUG 2021 (Official NBE)
| Q No. | Question |
|---|---|
| Q1 | a) Minimally invasive surgery - types and role in gynaecology b) Complications of laparoscopy |
| Q2 | a) Oocyte cryopreservation - indications, techniques b) Social egg freezing - ethical considerations |
| Q3 | a) Aneuploidy screening - first trimester combined screening b) NIPT - technique and applications |
| Q4 | a) Gestational surrogacy - legal and ethical issues in India b) ART regulation in India |
| Q5 | a) Platelet-rich plasma (PRP) in gynaecology b) Stem cell therapy in reproductive medicine |
| Q6 | a) Fetal therapy - interventional procedures b) Ex-utero intrapartum treatment (EXIT procedure) |
| Q7 | a) mRNA technology and its role in vaccines b) COVID-19 vaccine in pregnancy |
| Q8 | a) Fertility preservation - indications and methods b) Ovarian tissue transplantation |
| Q9 | a) Types of randomized controlled trials b) Meta-analysis - methodology and limitations |
| Q10 | a) NITI Aayog health indicators b) LaQshya programme |
🔥 Topic-wise Frequency Analysis (Most Repeated = High Priority)
| Topic | Years Asked |
|---|---|
| ART / IVF / ICSI / Embryo | 2021, 2022, 2022, 2023, 2024 - Every year |
| Robotic surgery | 2022, 2023 |
| Fetal medicine / NIPT / cfDNA | 2021, 2022, 2024 |
| MTP Act | 2023, 2024 |
| OHSS | 2023 |
| Maternal near miss | 2022, 2024 |
| Govt health programmes | Every year (SUMAN, RKSK, LaQshya, BFHI) |
| Cryopreservation / Fertility preservation | 2021, 2022 |
| Research methodology / Ethics | Every year |
| Hysteroscopy / Endoscopy | 2022, 2023 |
| ERAS | 2023 |
| Colour Doppler / Fetal blood transfusion | 2023 |
⚡ Priority Topics to Prepare (Appeared 3+ times)
- ART Regulation Act 2021 + Surrogacy Act 2021 - must know
- NIPT / cfDNA / Aneuploidy screening - every session
- Cryopreservation / Vitrification - every session
- Robotic surgery - theory + advantages/disadvantages
- Maternal near miss - definition, audit, etiologies
- Government programmes - SUMAN, LaQshya, RKSK, BFHI, KMC
- MTP Act 2021 amendments
- OHSS - classification + management
- Publication ethics + research methodology
- Fertility preservation - oncofertility
Tip: Paper 4 heavily mixes recent advances with government health programmes and research methodology. Always structure answers with a definition, classification, clinical details, and newer/recent aspects. Each question is 10 marks - aim for 8-10 well-organised points per sub-question.
This is a shared conversation. Sign in to Orris to start your own chat.